Interius BioTherapeutics is a preclinical stage gene therapy company developing novel methods for in vivo cell-specific gene delivery. It transforms cells through the in-vivo generation of therapeutic immune and blood cells including Chimeric Antigen Receptor T Cells (CAR-T) for cancers and regulatory T Cells (Treg) for autoimmune diseases.